After Court Win, Vanda Asks Makary To Review ‘Unacceptable’ Approval of Rival Generics
Vanda claims that two generics to its sleep disorder drug Hetlioz were approved despite inadequate data and is requesting that FDA Commissioner Marty Makary revisit the decision.
After Court Win, Vanda Asks Makary To Review ‘Unacceptable’ Approval of Rival Generics Read More »
